Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: Labcorp Holdings Inc.

Market Cap 21.2B 18.63B 17.16B 16.07B 30.11B 2,009B 30.61B 206B 79.78B 986B 79.6B 77.89B 3,425B P/E 2026 *
18x
P/E 2027 * 16.7x
Enterprise Value 25.84B 22.7B 20.92B 19.58B 36.68B 2,448B 37.3B 251B 97.22B 1,201B 97B 94.91B 4,174B EV / Sales 2026 *
1.75x
EV / Sales 2027 * 1.63x
Free-Float
99.65%
Yield 2026 *
1.13%
Yield 2027 * 1.14%
1 day+1.64%
1 week-2.33%
Current month-0.57%
1 month-0.52%
3 months-2.20%
6 months+2.15%
Current year+3.07%
1 week 253.05
Extreme 253.05
260.32
1 month 253.05
Extreme 253.05
275
Current year 245
Extreme 245
292.02
1 year 241.81
Extreme 241.81
293.72
3 years 191.97
Extreme 191.97
293.72
5 years 191.97
Extreme 191.97
317.17
10 years 98.02
Extreme 98.02
317.17
Date Insider Type Main position Quantity % Market Cap.
06-07Sell

General Counsel

-762 0.0009%
05-10Sell

Chief Executive Officer

-5,903 0.0072%
03-25Free

EVP, Operations

3,938 0.0048%
Change 5-day change 1-year change 3-year change Capi.($)
+1.64%-2.33%-0.94%+10.12% 20.86B
+2.60%+6.66%+37.79%+357.00% 32.77B
-0.81%-0.96%-24.85%-43.27% 6.86B
+0.79%-0.55%+2.42%+68.06% 4.38B
-0.13%+1.68%+19.09%+58.27% 2.96B
+4.80%-4.16%-27.14%+847.47% 1.65B
-1.38%-0.12%-12.97%-67.06% 1.68B
-1.22%+5.21%+39.20%-25.88% 1.77B
-0.92%+1.82%+13.65%-6.57% 1.59B
-2.32%-0.31%+38.76%+174.08% 1.44B
Average +0.32%+0.90%+8.50%+137.22% 7.6B
Weighted average by Cap. +1.53%+2.27%+15.74%+178.50%

Financials

2026 *2027 *
Net sales 14.76B 12.97B 11.95B 11.18B 20.95B 1,398B 21.31B 143B 55.53B 686B 55.4B 54.21B 2,384B 15.42B 13.55B 12.48B 11.68B 21.89B 1,461B 22.26B 150B 58.01B 717B 57.88B 56.64B 2,491B
Net income 1.18B 1.04B 957M 896M 1.68B 112B 1.71B 11.49B 4.45B 54.95B 4.44B 4.34B 191B 1.23B 1.08B 999M 935M 1.75B 117B 1.78B 12B 4.64B 57.36B 4.63B 4.53B 199B
Net Debt 4.63B 4.07B 3.75B 3.51B 6.58B 439B 6.69B 45.04B 17.44B 215B 17.4B 17.02B 749B 3.94B 3.46B 3.19B 2.99B 5.6B 374B 5.69B 38.33B 14.84B 183B 14.8B 14.48B 637B
Logo Labcorp Holdings Inc.
Labcorp Holdings Inc. provides comprehensive laboratory services that help doctors, hospitals, pharmaceutical companies, researchers and patients. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The BLS segment provides drug development and CDx development solutions from early-stage research to clinical development, along with support for crop protection and chemical testing, through its ED and Central Laboratory Services businesses. Its service also includes ambulatory outpatient laboratory services. The Company is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.
Employees
66,385
Date Price Change Volume
26-06-23 US$258.59 +1.64% 414,716
26-06-22 US$254.43 -0.54% 784,900
26-06-18 US$255.82 -1.44% 1,249,804
26-06-17 US$259.56 -1.96% 544,046
26-06-16 US$264.76 -0.10% 510,658
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
19
Last Close Price
258.59USD
Average target price
310.12USD
Spread / Average Target
+19.93%

Quarterly revenue - Rate of surprise

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!